Background: The aim of this study was to systematically evaluate the prognostic role of
platelet lymphocyte ratio (PLR) in patients with melanoma through performing a meta …

Background: The prognostic role of the platelet-to-lymphocyte ratio (PLR) is controversial in
patients with melanoma. Therefore, we performed a meta-analysis to assess the prognostic …

To investigate the prognostic role of the platelet‐to‐lymphocyte ratio (PLR) in melanoma
through a meta‐analytical method. The literature was searched using the PubMed, Embase …

Objectives This retrospective study aimed to investigate the prognostic value of pre-
treatment platelet-to-lymphocyte ratio (PLR), which is an inflammatory indicator, in patients …

Objective: To investigate whether platelet to lymphocyte ratio (PLR) in peripheral blood and
body mass index (BMI) can be independent prognostic factors in patients with melanoma …

Background: A number of studies have investigated the prognostic impact of the neutrophil-
to-lymphocyte ratio (NLR) in patients with melanoma but the results were controversial …

The prognostic value of the neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and
monocyte-lymphocyte ratio in patients with melanoma has yielded controversial results in …

Introduction Recently, the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) has
been widely evaluated in many cancers. Here we assessed the prognostic value of …

Background: Previous studies have suggested that an elevated pre-treatment neutrophil-to-
lymphocyte ratio (NLR) is associated with worse outcomes in patients with a variety of …

Immunotherapy has revolutionized the treatment in metastatic melanoma, but alternative
biomarkers that are economical, simple and reliable still need to be clarified. In this study …